Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen for Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
NCT03620929Phase 4Unknown
- Sponsor
- Fuxing Hospital, Capital Medical University
- Start
- Aug 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol valerate in Asherman syndrome (IUA), sponsored by Fuxing Hospital, Capital Medical University. Status: unknown.
02
Drugs
estradiol valerate
03
Conditions
Asherman syndrome (IUA)
Beyond the preview
Go deeper on NCT03620929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620929.